Comparison of drug survival between infliximab and adalimumab in inflammatory bowel disease

  1. Gil-Candel, M.
  2. Gascón-Cánovas, J.J.
  3. Urbieta-Sanz, E.
  4. Rentero-Redondo, L.
  5. Onteniente-Candela, M.
  6. Iniesta-Navalón, C.
Journal:
International Journal of Clinical Pharmacy

ISSN: 2210-7711,  2210-7703

Year of publication: 2020

Volume: 42

Issue: 2

Pages: 500-507

Type: Article

DOI: 10.1007/S11096-020-00978-6 GOOGLE SCHOLAR
Data source: Scopus